stockrowAvantor, Inc.
AVTR Healthcare Medical Instruments & Supplies
Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.
- Revenue
- +4.59%
- EPS
- +128.9%
- Free cash flow
- −9.03%
- Total debt
- −4.51%
Quarter to September 2026, against a year earlier
Follow AVTR
Alert me
Avantor, Inc. (AVTR) Revenue
Avantor, Inc.'s revenue for fiscal 2025 was $6.6B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $6.6B. Over the past ten years it has ranged from $691.0M (fiscal 2016) to $7.5B (fiscal 2022); the current reading is higher than 60% of that period. Revenue has fallen for 3 consecutive fiscal years. Avantor, Inc. ranks 7th of 47 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $6.6B | (3.41%) |
| FY2024 | $6.8B | (2.64%) |
| FY2023 | $7.0B | (7.26%) |
| FY2022 | $7.5B | 1.71% |
| FY2021 | $7.4B | 15.52% |
| FY2020 | $6.4B | 5.85% |
| FY2019 | $6.0B | 3.00% |
| FY2018 | $5.9B | 370.12% |
| FY2017 | $1.2B | 80.52% |
| FY2016 | $691.0M | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $1.7B | 0.35% |
| Jun 2026 | $1.7B | 7.01% |
| Mar 2026 | $1.6B | (4.94%) |
| Dec 2025 | $1.7B | 2.45% |
| 29 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| BAX Baxter International Inc. compare | $11.6B |
| SOLV Solventum Corporation compare | $8.2B |
| AVTR Avantor, Inc. | $6.6B |
| BLCO Bausch + Lomb Corporation compare | $5.4B |
| COO The Cooper Companies, Inc. compare | $4.2B |
| ALGN Align Technology, Inc. compare | $4.2B |
| ATR AptarGroup, Inc. compare | $4.0B |
| TFX Teleflex Incorporated compare | $2.3B |
| RGEN Repligen Corporation compare | $805.6M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on AVTR
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement